DPIIT Recognized Startup ยท DIPP224064

Advancing Life Sciences for
Healthier Tomorrow

ABAXISBIO PHARMA PVT. LTD. is a Bareilly-based pharmaceutical company at the forefront of Biotechnology and Medicine innovation. We are committed to developing affordable, high-quality therapeutic solutions for India and beyond.

Scroll
2018
Year Founded
2
Core Segments
DIPP224064
DPIIT Recognition
80-IAC
Tax Exemption Eligible
UP
Uttar Pradesh, India
Company Name
ABAXISBIO PHARMA PVT. LTD.
CIN
U74994UP2018PTC104627
Incorporated
24 May 2018
ROC
Kanpur, Uttar Pradesh
Status
โœ“ Active
Sector
Pharma & Life Sciences
๐Ÿ›๏ธ

DPIIT Recognized Startup

Startup India Initiative, Govt. of India

Recognition No: DIPP224064
Registered Address
N 86, North City Extension,
Bareilly, Uttar Pradesh โ€“ 243001
Virtual Address
Chandigarh Sector 17A, 3rd & 4th Floor,
SCO 54-55-56 Chandigarh โ€“ 160017

Pioneering Pharma Innovation from the Heart of India

Founded in 2018 in Bareilly, Uttar Pradesh, ABAXISBIO PHARMA PVT. LTD. was born from a vision to bridge the gap between cutting-edge biotechnology and affordable medicine. We believe healthcare breakthroughs should reach every patient, regardless of geography or income.

As a DPIIT-recognized startup under the Startup India initiative, we are committed to innovation, scalability, and nation-building through life sciences.

๐Ÿ”ฌ

Science-First Approach

Every product we develop is backed by rigorous research and evidence-based methodology.

๐Ÿ’Š

Affordable Access

We are committed to making high-quality medicines accessible to all segments of society.

๐ŸŒฑ

Scalable Innovation

Our business model is designed for rapid scale โ€” from Bareilly to Bharat and beyond.

Biotech & Generic
Product Pipeline

Dual-segment focus delivering both innovation-driven biologics and cost-effective generics.

Biotechnology ยท Segment A
Biologic Therapeutics

Development of recombinant proteins, monoclonal antibodies, and biosimilar formulations targeting chronic and life-threatening conditions.

Biosimilars Recombinant Proteins Oncology
Biotechnology ยท Segment B
Diagnostic Biologicals

Innovative biological diagnostic tools and reagents for accurate, rapid disease identification supporting healthcare infrastructure.

Diagnostics Immunoassay Point-of-Care
Generic Medicines ยท Segment A
Oral Solid Dosage Forms

High-quality generic tablets and capsules across therapeutic categories including cardiovascular, anti-diabetic, and anti-infective segments.

Tablets Capsules WHO-GMP
Generic Medicines ยท Segment B
Liquid Formulations

Sterile and non-sterile liquid formulations including syrups, suspensions, and injectable solutions for hospital and retail markets.

Injectables Syrups Sterile
Specialty ยท Segment C
Nutraceutical Blends

Science-backed nutraceutical combinations addressing nutritional deficiencies, immune support, and preventive healthcare needs.

Vitamins Minerals Immunity
Pipeline ยท Under Development
Next-Gen Drug Delivery

Research-stage novel drug delivery systems including nanoparticle formulations and targeted therapy platforms for enhanced bioavailability.

Nanotech Targeted Therapy R&D Stage

Research-Driven,
Innovation-Led Growth

Our innovation engine is at the core of everything we do. As a biotech and pharma startup, R&D is not a department โ€” it is our identity.

01

Biosimilar Development

Reverse-engineering and developing biosimilar versions of high-cost biologics to democratize access to life-saving treatments.

02

Generic Drug Optimization

Improving bioavailability and therapeutic efficacy of established generic molecules through advanced formulation science.

03

Process Innovation

Developing cost-efficient manufacturing processes that maintain quality while enabling competitive pricing for the mass market.

04

IP & Patent Strategy

Building intellectual property portfolio to protect innovations and establish long-term competitive moats in key therapeutic areas.

Why ABAXISBIO PHARMA Qualifies as an Innovative Startup

Under the Startup India framework, our dual focus on biotechnology and generic medicine represents a scalable, innovation-driven model with significant potential for employment generation and wealth creation in the Indian healthcare ecosystem.

Novel Biologic Formulations
Scalable Business Model
Technology-Driven Processes
Import Substitution Focus
Healthcare Accessibility
Employment Generation
Make in India Aligned
DPIIT Validated Innovation
Innovation Statement

"ABAXISBIO PHARMA is engaged in the innovation, development, and improvement of pharmaceutical products and biotechnology-based therapeutic solutions, with a scalable business model having high potential for employment generation and wealth creation."

Meet the Founders

Driven by expertise, passion, and a shared mission to transform Indian healthcare.

M
Manu Preet Singh
Director & Co-Founder

A visionary leader with deep expertise in pharmaceutical business development and life sciences. Manu Preet spearheads the company's strategic direction, partnerships, and growth initiatives, bringing entrepreneurial rigor to the Indian pharma landscape.

A
Anurag Saxena
Director & Co-Founder

An expert in pharmaceutical sciences and operations management, Anurag oversees product development, regulatory compliance, and manufacturing strategy. His technical acumen drives ABAXISBIO's innovation pipeline and quality standards.

Regulatory Standing & Government Recognition

ABAXISBIO PHARMA meets all eligibility criteria for startup benefits under the Government of India's Startup India initiative.

โœ“
DPIIT Recognized Startup โ€” No. DIPP224064
โœ“
Incorporated under Companies Act 2013 as Pvt. Ltd.
โœ“
ROC Registration โ€” Registrar of Companies, Kanpur
โœ“
Incorporated after April 1, 2016 โ€” Eligible for 80-IAC
โœ“
Age less than 10 years โ€” Startup India compliant
โœ“
Innovation-driven model validated by DPIIT
โœ“
MCA Active Status โ€” CIN: U74994UP2018PTC104627

Section 80-IAC Tax Exemption

As a DPIIT-recognized startup incorporated after April 1, 2016, ABAXISBIO PHARMA PVT. LTD. is eligible to apply for 100% income tax exemption under Section 80-IAC of the Income Tax Act, 1961.

100%

Income Tax Exemption

For 3 consecutive years out of a block of 7 years from incorporation

7

Year Block Period

Flexibility to choose the best 3 profitable years within the 7-year window

Also Eligible For
  • โ†’ Self-certification under 9 Labour Laws
  • โ†’ 50% rebate on Patent & Trademark filing
  • โ†’ Government Tender fast-track access
  • โ†’ Startup India Seed Fund eligibility

Connect With Us

For partnerships, distribution inquiries, investor relations, or general queries, we'd love to hear from you.

๐Ÿ“

Registered Office

N 86, North City Extension,
Bareilly, Uttar Pradesh โ€“ 243001
India

๐Ÿข

Virtual Address

Chandigarh Sector 17A, 3rd & 4th Floor,
SCO 54-55-56 Chandigarh โ€“ 160017
India

โœ‰๏ธ

Email

abaxisbio@gmail.com

๐Ÿ›๏ธ

DPIIT Recognition

DIPP224064
Startup India Initiative, Govt. of India

๐Ÿ“‹

Corporate Identity

CIN: U74994UP2018PTC104627
ROC: Kanpur, Uttar Pradesh

Send Us a Message